A Prospective Study of Cardiovascular Risk of Patients Admitted for Acute Exacerbation of COPD

Starting soon · Not applicable

Conditions studied: COPD

In brief

This is a prospective study to assess the burden of existing or hidden cardiovascular (CV) and renal disease in patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) in a Hong Kong public hospital setting. By implementing a chronic obstructive pulmonary disease (COPD) discharge care bundle with integrated CV/renal screening, the study aims to quantify undiscovered disease prevalence, evaluate risk factors for future exacerbations, and compare re-admission rates against historical controls, ultimately informing integrated cardiopulmonary management strategies.

Key facts

Study ID

NCT07344285

Run by

Chinese University of Hong Kong

People needed

150

Starts

2026-01-15

Expected to finish

2029-02-28

Last updated by the study team

2026-01-21

Who can join

Age: 40 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age ≥40 years
• Patients hospitalized due to COPD exacerbation.
• Patients diagnosed with COPD, a confirmed COPD diagnosis with a specific FEV1/FVC ratio (<0.70)
• Able to provide informed consent

You may not qualify if…

• Pregnant subjects
• Inability to give informed consent
• Cancer patient who are on active chemotherapy or on palliative care

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.